Erythromelalgia (EM ... The condition was formerly known as Mitchell’s disease after American physician and writer Silas Weir Mitchell. It’s estimated that EM affects an estimated 0.36 ...

In cases of erythromelalgia that are secondary to hematological or myeloproliferative disease, symptoms can respond dramatically to treatment with aspirin, with patients experiencing several days ...

Erythromelalgia (sometimes called erythermalgia) is characterized by episodes of burning pain, skin redness, and swelling of the extremities, ears and face. The pain can be severe, and is ...

Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Navega is pursuing a radically different approach for treatment of chronic pain associated with rare diseases and other common intractable chronic pain conditions such primary erythromelalgia and ...

The company currently has two therapeutic programs in development, including peripheral neuropathy caused by erythromelalgia, which is an orphan disease, (ADB-101), and Adolore's lead program (ADB ...